- $133.52m
- $51.35m
- $51.60m
- 91
- 36
- 85
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33 | 37.6 | 40.3 | 46.1 | 51.6 |
Cost of Revenue | |||||
Gross Profit | 23.1 | 26.8 | 28.9 | 33.3 | 37.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40.8 | 42.1 | 45.8 | 50.2 | 52.3 |
Operating Profit | -7.83 | -4.58 | -5.49 | -4.11 | -0.662 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.66 | -3.77 | -5.14 | -2.1 | 3.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.83 | -3.99 | -5.26 | -2.26 | 3.71 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.83 | -3.99 | -5.26 | -2.26 | 3.71 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.83 | -3.99 | -5.26 | -2.26 | 3.71 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.496 | -0.287 | -0.373 | -0.155 | 0.243 |